Author: Nervonik Inc.

Nervonik Announces Completion of Groundbreaking First-in-Human Feasibility Study Demonstrating Nerve Sensing during Peripheral Nerve Stimulation in Multiple Anatomical Targets

June 16, 2026
Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapy

May 20, 2026

Nervonik Announces Completion of Groundbreaking First-in-Human Feasibility Study Demonstrating Nerve Sensing during Peripheral Nerve Stimulation in Multiple Anatomical Targets